BridgeMD
New treatment option for Sleep Apnea, Obstructive
Official title Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
ClinicalTrials.gov ID: NCT05939934
What this study is testing
- What it's testing
- Obstructive sleep apnea hypopnea syndrome (OSAS) is a frequent disease with neuropsychological and cardiovascular (CV) consequences. Continuous positive pressure (CPAP), the main treatment for OSAHS, is effective on the majority of symptoms but restrictive, which can promote non-compliance.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patient accepting MAD treatment
- Patient with an apnea-hypopnea index (AHI) greater than 15 events per hour on the initial recording
- Patient with excessive daytime sleepiness during initial treatment (ESE\>10)
- Patient treated for more than 12 months by CPAP with average compliance greater than 5 hours per night
You likely can't join if
- Initial severe daytime sleepiness characterized
- OSAS with ≥ 5 central apneas per hour of sleep at baseline recording
- Previously diagnosed severe cardiac and/or respiratory pathology:
- Body mass index ≥ 35 kg/m2
- Known contraindication to OAM treatment
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.